University research records
American University of Beirut
8 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →8 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to American University of Beirut are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–8 of 8 matching records. Counts update as records arrive.
Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity
March 1, 2026 · 0 citations · Open access
Open original record →GLP1 receptor agonists and SGLT2 inhibitors for the prevention or delay of type 2 diabetes mellitus onset: a systematic review and meta-analysis
October 23, 2025 · 6 citations · Open access
Open original record →Hormones and Aging: An Endocrine Society Scientific Statement
June 16, 2023 · 89 citations · Open access
Open original record →SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism
March 16, 2023 · 27 citations · Open access
Open original record →SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
February 29, 2020 · 52 citations · Open access
Open original record →Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
August 29, 2017 · 53 citations · Open access
Open original record →Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
May 1, 2017 · 10 citations · Open access
Open original record →Macrovascular Complications in Patients with Diabetes and Prediabetes
January 1, 2017 · 280 citations · Open access
Open original record →